This just in at the Health Care Blog’s New York Desk … The U.S. Food and Drug Administration has ordered Pfizer to withdraw Bextra from the market and urged "the possible strongest warning" for it’s fellow Cox-2 inhibitor Celebrex.   See the AP story for details.UPDATE: Read the FDA press release here.